Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
Authors
Keywords
-
Journal
DRUGS
Volume 72, Issue 13, Pages 1765-1791
Publisher
Springer Nature
Online
2012-08-30
DOI
10.2165/11209630-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults
- (2014) Wayde M. Weston et al. Human vaccines & immunotherapeutics
- Whooping Cough in Adults: An Update on a Reemerging Infection
- (2012) Robert D. Paisley et al. AMERICAN JOURNAL OF MEDICINE
- Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials
- (2012) Wayde M. Weston et al. VACCINE
- Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling
- (2011) David N Fisman et al. BMC PUBLIC HEALTH
- The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization
- (2011) D. M. Skowronski et al. CLINICAL INFECTIOUS DISEASES
- Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women
- (2011) B. A. Halperin et al. CLINICAL INFECTIOUS DISEASES
- Pertussis vaccines: where to now?
- (2011) Jan T Poolman et al. Expert Review of Vaccines
- Extensive Limb Swelling after Vaccination
- (2011) Benedikt M. Huber et al. JOURNAL OF PEDIATRICS
- Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age
- (2011) Cosette M. Wheeler et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants
- (2011) Elke Leuridan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Additional Recommendations for Use of Tetanus Toxoid, Reduced-Content Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap)
- (2011) PEDIATRICS
- Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
- (2011) Pierre Van Damme et al. VACCINE
- Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2010
- (2011) Pedro L. Moro et al. VACCINE
- Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
- (2011) Wayde Weston et al. VACCINE
- Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4–6 years old
- (2011) Patrick Quinn et al. VACCINE
- Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose
- (2011) Scott A. Halperin et al. VACCINE
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Effectiveness of Adolescent and Adult Tetanus, Reduced‐Dose Diphtheria, and Acellular Pertussis Vaccine against Pertussis
- (2010) Stanley C. Wei et al. CLINICAL INFECTIOUS DISEASES
- Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults
- (2010) Jussi Mertsola et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
- (2010) Tjalke A. Westra et al. CLINICAL THERAPEUTICS
- Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial
- (2010) Jean Beytout et al. Human vaccines & immunotherapeutics
- Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
- (2010) Fengcai Zhu et al. Human vaccines & immunotherapeutics
- Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance Organization
- (2010) Nicola P. Klein et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
- (2010) Robin de Vries et al. PLoS One
- Contact Network Structure Explains the Changing Epidemiology of Pertussis
- (2010) P. Rohani et al. SCIENCE
- A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
- (2010) Robert Booy et al. VACCINE
- Immunogenicity and reactogenicity of co-administered tetanus–diphtheria–acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration
- (2010) Wayde M. Weston et al. VACCINE
- Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®)†
- (2009) Greg L. Plosker BIODRUGS
- The epidemiology of pertussis in Germany: past and present
- (2009) Wiebke Hellenbrand et al. BMC INFECTIOUS DISEASES
- PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA
- (2009) Claudia Rank et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects
- (2009) Laurent Coudeville et al. PLoS One
- An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink
- (2009) W. Katherine Yih et al. VACCINE
- Cost-effectiveness of adult pertussis vaccination in Germany
- (2008) Grace M. Lee et al. VACCINE
- Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
- (2008) Mark Blatter et al. VACCINE
- Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination
- (2008) Peter B. McIntyre et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More